BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6201402)

  • 21. Re: Subcutaneous urinary diversions for palliative treatment of pelvic malignancies.
    Irani J; Aubert J
    J Urol; 1996 Sep; 156(3):1137. PubMed ID: 8709328
    [No Abstract]   [Full Text] [Related]  

  • 22. Survival and quality of life after percutaneous nephrostomy for malignant ureteric obstruction in patients with terminal cervical cancer.
    Emmert C; Rassler J; Köhler U
    Arch Gynecol Obstet; 1997; 259(3):147-51. PubMed ID: 9187468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Is supravesical urinary diversion in terminal gynecologic cancer indicated?].
    Eisenmenger M; Höbarth K; Eglau K; Hofbauer H
    Gynakol Rundsch; 1991; 31 Suppl 2():251-2. PubMed ID: 1724227
    [No Abstract]   [Full Text] [Related]  

  • 24. Percutaneous urinary diversion in patients with hormone-refractory prostate cancer.
    Dowling RA; Carrasco CH; Babaian RJ
    Urology; 1991 Feb; 37(2):89-91. PubMed ID: 1992595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Palliative Subcutaneous Tunneled Nephrostomy Tube (PSTN): a simple and effective technique for management of malignant extrinsic ureteral obstruction.
    Bell DG; Fischer MA
    Can J Urol; 2002 Feb; 9(1):1470-4. PubMed ID: 11886602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilization of the intestine in surgery for major urological complications following gynaecological cancer.
    Kontturi M; Larmi TK
    Ann Chir Gynaecol Fenn; 1972; 61(6):306-11. PubMed ID: 4119642
    [No Abstract]   [Full Text] [Related]  

  • 27. Renal and urologic problems: management of ureteric obstruction.
    Liberman D; McCormack M
    Curr Opin Support Palliat Care; 2012 Sep; 6(3):316-21. PubMed ID: 22643703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome of Palliative Urinary Diversion and Observation for Malignant Extrinsic Ureteral Obstruction.
    Tatenuma T; Tsutsumi S; Yasui M; Noguchi G; Umemoto S; Kishida T
    J Palliat Med; 2020 Feb; 23(2):254-258. PubMed ID: 31834827
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute obstructive renal failure secondary to granulocytic sarcoma (chloroma).
    Steinbock GS; Morrisseau PM; Vinson RK
    Urology; 1986 Mar; 27(3):268-70. PubMed ID: 3082059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Urinary diversion in patients with carcinoma of the cervix and ureteral obstruction: a call to attention].
    Torres Ramírez C; Zuluaga Gómez A; Fernández Ore N; Puebla Ceverino M; Navarro A
    Arch Esp Urol; 1985; 38(3):259-65. PubMed ID: 4062368
    [No Abstract]   [Full Text] [Related]  

  • 31. Passive ileal segment urinary diversion in advanced cervical carcinoma--a retrospective review.
    Ngotho D; Pather S; Moodley J; Ramphal S
    S Afr J Surg; 2000 May; 38(1):4-6. PubMed ID: 12365118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Extra-anatomic urinary diversion by subcutaneous catheter].
    Pérez Sanz P; Pozo Mengual B; Marcén Letosa R; Pascual Santos J; Burgos Revilla FJ
    Actas Urol Esp; 2004 Apr; 28(4):314-7. PubMed ID: 15248404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients.
    Cordeiro MD; Coelho RF; Chade DC; Pessoa RR; Chaib MS; Colombo-Júnior JR; Pontes-Júnior J; Guglielmetti GB; Srougi M
    BJU Int; 2016 Feb; 117(2):266-71. PubMed ID: 25327474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracorporeal urinary bypass for malignant ureteral obstruction.
    Tomooka Y; Yokoyama M; Takeuchi M
    Urology; 1994 Jun; 43(6):878-9. PubMed ID: 8197655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcutaneous nephrovesical and nephrocutaneous bypass.
    Jurczok A; Loertzer H; Wagner S; Fornara P
    Gynecol Obstet Invest; 2005; 59(3):144-8. PubMed ID: 15637433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous ureterostomy as palliative diversion in adults with malignancy.
    MacGregor PS; Montie JE; Straffon RA
    Urology; 1987 Jul; 30(1):31-4. PubMed ID: 2440171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcome and management of ureteral obstruction secondary to gastric cancer.
    Migita K; Watanabe A; Samma S; Ohyama T; Ishikawa H; Kagebayashi Y
    World J Surg; 2011 May; 35(5):1035-41. PubMed ID: 21387134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Surgical diversion of the upper urinary tract in disorders of the urinary flow caused by malignant tumors in the lower abdomen. Indication and results].
    Heinrich W
    Urologe; 1967; 6(5):306-12. PubMed ID: 4173908
    [No Abstract]   [Full Text] [Related]  

  • 39. [Results of ureterocystoneostomy for inner urinary diversion in locally advanced prostate carcinoma].
    Wawroschek F; Hamm M; Rathert P
    Urologe A; 1998 Jul; 37(4):372-6. PubMed ID: 9738288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary diversion for ureteral obstruction in the presence of recurrent colon carcinoma.
    Schoenberg HW; Lyles TO; Karlin D; Levin B
    J Urol; 1979 Sep; 122(3):315-6. PubMed ID: 89205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.